Carcinoembryonic antigen (CEA), a broad-spectrum tumor marker, is highly expressed in ovarian cancer, colon cancer, breast cancer, lung cancer, and other malignant tumors, and has been employed as a receptor that targets tumors (Meller et al., 2011). The gene discussed is CEACAM5; the disease is lung cancer.